Iron overload, either at the systemic or at the cellular levels, is also associated with harmful effects on cardiac function, as has been demonstrated in animal studies using mice with cardiomyocyte-specific deletion of the ferroportin gene as well as in humans with hemochromatosis or β-thalassemia [30,31]. This evidence concerns the gene SLC40A1 and hemochromatosis type 1.